ABOUT ME

Dr Sarah Shigdar has been developing aptamers, or chemical antibodies, since 2009. Her work has been recognised locally through the Smart Geelong Awards (2011 and 2013), nationally by the CASS Foundation (2013) and internationally by the International Society on Aptamers (INSOAP), who asked her to take on the role of President in 2016.

EDUCATION

RESEARCH INTERESTS

Aptamers

The development of aptamers as therapeutic and companion diagnostic agents

2005 - 2009

Deakin University

PhD Haematology

Cancer

Developing novel therapeutic strategies to target epithelial cancers

Neurodegenerative diseases

Generating bi-functional aptamers to increase bioavailability of drugs to treat CNS disorders

2002 - 2004

RMIT

MSc Applied Science (Med. Lab. Sci.)

1992 - 1995

University of Wolverhampton

BSc (Hons) Biological Sciences (Biomed Sci.)